Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
From black box to clear box: explainable AI for next-gen pharmacovigilance
0
Zitationen
3
Autoren
2026
Jahr
Abstract
The EU AI Act classifies PV algorithms as 'high-risk,' imposing strict requirements for human oversight and transparency, aligning with the FDA's GMLP and India's Responsible AI principles. The review emphasizes traceability and governance, recommending convergence with human oversight into a regulatory-fit XAI framework to maximize safety signal detection and foster international trust in AI-based decision-making.
Ähnliche Arbeiten
A method for estimating the probability of adverse drug reactions
1981 · 11.473 Zit.
Incidence of Adverse Drug Reactions in Hospitalized Patients
1998 · 4.800 Zit.
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients
2004 · 3.198 Zit.
Adverse drug reactions: definitions, diagnosis, and management
2000 · 2.937 Zit.
Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group
1995 · 2.509 Zit.